Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA tobacco regulation bill

This article was originally published in The Tan Sheet

Executive Summary

Senate HELP Committee in a July 18 executive session marks up the heavily supported bipartisan "Family Smoking Prevention and Tobacco Control Act," S. 625, aimed to reduce youth smoking via FDA regulatory authority over tobacco products. Committee Chairman and bill co-sponsor Edward Kennedy, D-Mass., says the bill would provide FDA power to block under-18 cigarette purchases and misleading manufacturer information on dangers of smoking. Under the bill's provisions, tobacco products would be subject to FDA review prior to marketing and the agency would have the authority to withhold health-related claims approval for products unverified by the agency. "These safeguards are essential to prevent deceptive industry marketing campaigns, which could lull the public into a false sense of health safety," Kennedy notes...
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS100725

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel